H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: Prompt antiviral therapy might be life saving

Transplant Infectious Disease

Volumn 13, Issue 2, 2011, Pages 208-212

  Suyani, E ^a   Aki, Z ^a   Guzel O ^a   Altindal, S ^a   Senol E ^a   Sucak, G ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Antiviral therapy; H1N1; Hematological malignancies; Hematopoietic stem cell transplantation; Immunosuppressed patients; Influenza; Oseltamivir

Indexed keywords

OSELTAMIVIR;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); MALE; MIXED INFECTION; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORAX RADIOGRAPHY;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79953304044     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00569.x     Document Type: Article

References (12)

1. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc 2010; 85: 64-76.
2. Sharon B, Schleiss MR. Pandemic influenza A (H1N1). Pediatr Res 2009; 66: 599.
3. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010; 38 (4, Suppl): e52-e57.
4. Seiter K, Nadelman RB, Liu D, Ahmed T, Montecalvo MA. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010; 28: 27-29.
5. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244-247.
6. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306.
7. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006; 85: 278-287.
8. Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood 2010; 115 (7): 1331-1342.
9. World Health Organization (WHO). CDC protocol of realtime RTPCR for influenza A (H1N1). Available at (Accessed April 30, 2009).
10. Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, Sandin R. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 2010; 91: 124-127.
11. Machado CM, Boas LSV, Mendes AVA, et al. Use of Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 111-114.
12. Khanna N, Steffen I, Studt JD, et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009; 11 (2): 100-105.